GSK plc reported the purchase of 6,233,812 ordinary shares for its treasury as part of a buyback program, with transactions ranging from June 1 to June 5, 2026, at prices between £18.32 and £19.39 per share. The total number of shares in issue is now 4,048,628,915, with 6.61% held as treasury shares.